Number of the records: 1  

Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma

  1. 1.
    SYSNO ASEP0555718
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleActivation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
    Author(s) Vendramin, R. (BE)
    Katopodi, V. (BE)
    Cinque, S. (BE)
    Konnova, A. (BE)
    Knezevic, Z. (BE)
    Adnane, S. (BE)
    Verheyden, Y. (BE)
    Karras, P. (BE)
    Demesmaeker, E. (BE)
    Bosisio, F. (BE)
    Kučera, Lukáš (UMG-J)
    Rozman, Jan (UMG-J)
    Gladwyn-Ng, I. (DE)
    Rizzotto, L. (BE)
    Dassi, E. (IT)
    Millevoi, S. (FR)
    Bechter, O. (BE)
    Marine, J. (BE)
    Leucci, E. (BE)
    Number of authors19
    Article numbere20210571
    Source TitleJournal of Experimental Medicine. - : Rockefeller University Press - ISSN 0022-1007
    Roč. 218, č. 9 (2021)
    Number of pages27 s.
    Publication formOnline - E
    Languageeng - English
    CountryUS - United States
    Keywordsmitochondrial translation ; drug-tolerant ; cancer ; resistance ; metabolism ; atf4 ; dysfunction ; doxycycline ; transition ; microbiome
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsLM2018126 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF16_013/0001789 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Research InfrastructureCCP II - 90126 - Ústav molekulární genetiky AV ČR, v. v. i.
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000704364600005
    DOI10.1084/jem.20210571
    AnnotationThe ability to adapt to environmental stress, including therapeutic insult, contributes to tumor evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR) promotes survival by dampening cytosolic translation. We show that ISR-dependent survival also relies on a concomitant up-regulation of mitochondrial protein synthesis, a vulnerability that can be exploited using mitoribosome-targeting antibiotics. Accordingly, such agents sensitized to MAPK inhibition, thus preventing the development of resistance in BRAFV600E melanoma models. Additionally, this treatment compromised the growth of melanomas that exhibited elevated ISR activity and resistance to both immunotherapy and targeted therapy. In keeping with this, pharmacological inactivation of ISR, or silencing of ATF4, rescued the antitumoral response to the tetracyclines. Moreover, a melanoma patient exposed to doxycycline experienced complete and long-lasting response of a treatment-resistant lesion. Our study indicates that the repurposing of mitoribosome-targeting antibiotics offers a rational salvage strategy for targeted therapy in BRAF mutant melanoma and a therapeutic option for NRAS-driven and immunotherapy-resistant tumors.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2022
    Electronic addresshttps://rupress.org/jem/article/218/9/e20210571/212494/Activation-of-the-integrated-stress-response
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.